Medicinal cannabis
Alternative labels
Medical cannabis
Report
Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Regulation of Personal Adult Use of Cannabis) Bill 2023
An inquiry into a bill to decriminalise cannabis for personal use introduced into the Parliament of Victoria. This report considers the operation of similar legislative amendments in the ACT and other evidence on cannabis decriminalisation. It recommends a range of amendments to the Bill.
Report
Impact of the regulatory framework for cannabis in New South Wales
The committee has been informed by a substantial body of evidence that has shaped its view that law reform regarding the regulation of cannabis in New South Wales is not only urgently needed but is also the only rational course of action. This first report makes several preliminary findings and recommendations for law reform.
Report
Inquiry into workplace drug testing in Victoria
The purpose of this Inquiry is to investigate the legislative and regulatory framework for workplace drug testing, including the treatment of prescription medicinal cannabis compared to other prescription medications. The Committee aimed to understand whether the framework can be improved and whether current workplace drug testing laws and procedures are discriminatory.
Briefing paper
Transport Legislation Amendment Bill 2023: Bill Brief
The Transport Legislation Amendment Bill 2023 introduces a number of amendments across Victoria’s transport framework. The most heavily publicised provision is the introduction of a closed-track trial to investigate how medicinal cannabis users can drive safely. This Bill Brief examines the amendments relating specifically to the road safety trial.
Report
Current barriers to patient access to medicinal cannabis in Australia
This report recommends that Australia's Therapeutic Goods Administration (TGA) review and improve its online resources for health professionals relating to the regulations and processes for prescribing medicinal cannabis through the Special Access Scheme and Authorised Prescriber pathways.